Kadinfection prevention and control guideline for cystic fibrosis: 2013 update

Lisa Saiman, Jane D. Siegel, John J. LiPuma, Rebekah F. Brown, Elizabeth A. Bryson, Mary Jo Chambers, Veronica S. Downer, Jill Fliege, Leslie A. Hazle, Manu Jain, Bruce C. Marshall, Catherine O'Malley, Suzanne R. Pattee, Gail Potter-Bynoe, Siobhan Reid, Karen A. Robinson, Kathryn A. Sabadosa, H. Joel Schmidt, Elizabeth Tullis, Jennifer WebberDavid J. Weber

Research output: Contribution to journalArticlepeer-review

312 Scopus citations


In summary, epidemiologic studies have shown that pathogens, other than Burkholderia spp., can be transmitted among individuals with CF, resulting in adverse clinical outcomes, including increased morbidity and mortality. The updated guideline is a response to new knowledge and new challenges in both IP&C and CF. The primary objective of the guideline is to provide recommendations to reduce the risk of transmission and acquisition of CF pathogens by individuals with CF and to provide a more comprehensive understanding of effective strategies to optimize safety for this unique population.

Original languageEnglish (US)
Pages (from-to)S1-S67
JournalInfection Control and Hospital Epidemiology
Issue numberSUPPL.1
StatePublished - Aug 2014

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Epidemiology


Dive into the research topics of 'Kadinfection prevention and control guideline for cystic fibrosis: 2013 update'. Together they form a unique fingerprint.

Cite this